Skip to content

AGEN

Healthcare · −9.6% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 8 feeds behind: FDA drug approvals, 1 day, and 7 more · Every feed →

On this page

The market view

Price chart

The interactive AGEN chart (by TradingView) loads here.

Our take

5 rules fired on AGEN

In short: none of these rules has solid or some evidence yet, so they show no clear lean on AGEN.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

All 5 rules
The 0–100 score for AGEN, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on AGEN, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Is disclosure activity unusual?

No insider or Congress trades of AGEN are on file, so there is no history to compare. Missing records do not mean no one traded.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

FDA & trials

Owners & lobbying

All 11 records in this snapshot
  1. Filed
  2. Filed
  3. Filed
  4. Filed
  5. Record date
  6. Filed
  7. Filed
  8. Filed
  9. Filed
  10. Record date
  11. Record date

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on AGEN disclosed in the last 90 days.

See every Congress trade on AGEN →

Company insiders

No insider buys or sells of AGEN filed in the last 90 days.

See every insider trade on AGEN →

Big holders (Schedule 13D / 13G): 2 filings in the last 90 days · newest: BlackRock, Inc. (13G), Jul 27, 2026 ↗

Filings & events

Company filings (8-K) 62

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Quarterly or yearly results · item 2.029
  • Signed a major agreement · item 1.016
  • Directors or officers joined, left or got new pay · item 5.026
  • Other events · item 8.015
  • Sold shares privately · item 3.024
  • Shared information with investors · item 7.014

Filing red flags 38

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

FDA and clinical trials 6

Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.

5% owners (13D / 13G) 4

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 1 filing
  • 13G, just holds: 3 filings

Filed by BlackRock, Inc. · Ra Capital Management, L.P. · Invus Global Management, LLC · Zynext Ventures USA LLC

Biggest named funds (13F)

The largest AGEN holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on AGEN

No disclosed trades on AGEN yet — the feeds fill in at the next data publish.

See the trades on AGEN in the feed →
People & votes

Which members of Congress traded AGEN, sponsored bills that touch it and voted on them — opens here.